News

SPERA PHARMA will be exhibiting at CPHI Japan 2025 which will be held at Tokyo Big Sight from April 9th to 11th, 2025. SPERA NEXUS, Inc., part of Astena Group and engaged in the fine chemicals business, will a...

We are pleased to announce that Mitsuhisa Yamano from our Chemical R&D Laboratory has contributed to the following book, published in November 2024.   ♦Book Title: [ Continuous Manufacturing Pro...

A new research paper by Dr. Keiyo Nakai et al. has been published in the academic journal "Crystal Growth & Design of the American Chemical Society.   Journal: 　      Crystal Growth & Desig...

At SPERA PHARMA, we have added the latest 3D ED/MicroED (Three-Dimensional Electron Diffraction/Microcrystal Electron Diffraction) to our conventional X-ray analysis lineup, paving the way for a new chapter in...

[pdf-embedder url="https://www.spera-pharma.co.jp/wp-content/uploads/2022/09/220916_news_Notice-of-Change-of-Board-Members.pdf" title="220916_news_Notice of Change of Board Members"]

Osaka (Japan), February 16, 2022 – Interprotein Corporation and SPERA PHARMA, Inc. today hereby announce that we have signed an agreement for comprehensive collaboration aiming at research & development, m...

A paper by Masatoshi Yamada and others of the Pharmaceutical Research Division has been published in the academic journal "Organic Process Research & Development" of the American Chemical Society. 【Det...

A paper by Masatoshi Yamada and others of the Pharmaceutical Research Division has been published in the academic journal "Organic Process Research & Development" of the American Chemical Society. 【Det...

A paper by Masatoshi Yamada and others of the Pharmaceutical Research Division has been published in the academic journal "Organic Process Research & Development" of the American Chemical Society. 【Det...